BioSpace News Archive

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 11:15 a.m. E.T.

Ayala Pharmaceuticals, Inc. today announced its key objectives for 2022.

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced that its management team will give a presentation at the H.C. Wainwright BIOCONNECT Virtual Conference.

Vor Biopharma, a clinical-stage cell and genome engineering company, announced that members of its senior management team will be participating in two upcoming virtual investor conferences.

Longeveron Inc. announced that Geoff Green, Chief Executive Officer of Longeveron, will present at the H.C. Wainwright & Co. BioConnect 2022 Virtual Conference, and participate in a panel discussion moderated by Dr. Scott Gottlieb, the former commissioner of the U.S. Food and Drug Administration.

Universe Pharmaceuticals INC today announced that the Company had entered into two strategic cooperation agreements (the “Agreements”) with Jiangxi Province Institute of Materia Medica.

Centogene N.V. announced the global release of CentoCloud, a SaaS platform enabling decentralized analysis, interpretation, and reporting of genomic variants linked to rare diseases.

Perrigo Company plc (NYSE; TASE: PRGO), announced today that President and CEO, Murray S. Kessler is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 3:45 PM (EST) .

RTI Surgical, a global private label OEM company, announced that the company will spin off its Metals business, creating two independent companies that are focused on the needs of customers and patients in their distinct market segments.

Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the H.C. Wainwright Virtual BioConnect Conference being held from January 10-13, 2022.